NIH Guide for Grants and Contracts
July 31, 2020
Weekly NIH Funding Opportunities and Notices

Policy Notices

General Notices

Notice of Changes to Funding Opportunities

Notices of Intent to Publish

Requests for Proposal

Funding Opportunities

  • Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)
    (PA-20-252)
    Office of Dietary Supplements
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): October 15, 2020, January 15, 2021, April 15, 2021, October 15, 2021, January 17, 2022, and April 15, 2022, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional)
    (PAR-20-254)
    National Human Genome Research Institute
    National Cancer Institute
    National Eye Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities
    National Institute of Neurological Disorders and Stroke
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): New Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023 Renewal, Resubmission and Revision Due Dates: November 17 2020, March 17 2021, July 19 2021, November 17 2021, March 17 2022, July 19 2022, November 17 2022, March 17 2023, July 19 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) (Clinical Trial Optional)
    (PAR-20-255)
    National Human Genome Research Institute
    National Cancer Institute
    National Eye Institute
    National Institute on Aging
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): New Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023 Resubmission and Revision Due Dates: November 17 2020, March 17 2021, July 19 2021, November 17 2021, March 17 2022, July 19 2022, November 17 2022, March 17 2023, July 19 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional)
    (PAR-20-257)
    National Human Genome Research Institute
    John E. Fogarty International Center
    National Cancer Institute
    National Institute on Aging
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): New Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023 Resubmission and Revision Due Dates: November 17 2020, March 17 2021, July 19 2021, November 17 2021, March 17 2022, July 19 2022, November 17 2022, March 17 2023, July 19 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)
    (PAR-20-279)
    National Institute on Drug Abuse
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): December 15, 2020; August 10, 2021; December 14, 2021; August 10, 2022; December 14, 2022; August 10, 2023

  • NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
    (PAR-20-285)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): New Applications: October 14, 2020; February 18, 2021; June 18, 2021; October 14, 2021; February 22, 2022; June 20, 2022; October 18, 2022; February 14, 2023, June 14, 2023 by 5:00 PM local time of applicant organization. Resubmission or Revision Applications: November 18, 2020; March 22, 2021; July 14, 2021; November 18, 2021, March 22, 2022; July 20, 2022; November 18, 2022; March 14, 2023, July 23, 2023 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Transition to Aging Research for Predoctoral Students (F99/K00)
    (RFA-AG-21-022)
    National Institute on Aging
    Application Receipt Date(s): October 22, 2020

  • Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)
    (RFA-AG-21-029)
    National Institute on Aging
    Application Receipt Date(s): November 10, 2020 No late applications will be accepted for this Funding Opportunity Announcement.

  • Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
    (RFA-AR-21-008)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): October 19, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date..

  • NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)
    (RFA-DK-20-024)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): January 06, 2021

  • Limited Competition: Data Coordinating Center (DCC) for Completion of Ongoing MFMU Network Protocols (U24 Clinical Trial Optional)
    (RFA-HD-21-028)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): September 4, 2020

  • Limited Competition: Clinical Centers for Completion of Ongoing MFMU Network Protocols (UG1 Clinical Trial Optional)
    (RFA-HD-21-029)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): September 4, 2020

  • Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional)
    (RFA-HG-20-048)
    National Human Genome Research Institute
    National Cancer Institute
    Application Receipt Date(s): October 28, 2020 and July 8, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Investigator-Initiated Research on Genetic Counseling Processes and Practices (R21, Clinical Trial Optional)
    (RFA-HG-20-049)
    National Human Genome Research Institute
    Application Receipt Date(s): October 28, 2020 and July 8, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • The NINDS Human Biospecimen and Data Repository (U24 Clinical Trial Not Allowed)
    (RFA-NS-20-031)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): October 20, 2020